PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
24-Jul-2025 New Study: Hospital Affiliation Key Driver of Surging Cost of Outpatient Care ACCESS Newswire
24-Jul-2025 CDx Diagnostics Receives FDA Breakthrough Device Designation for Its WATS3D Test System for Esophageal Cancer ACCESS Newswire
24-Jul-2025 Clinicians Benchmark Real-World AI Performance in Clinical Workflows: Survey Evaluates Safety, Accuracy, and Automation Readiness ACCESS Newswire
24-Jul-2025 SurgiVance Inc. Receives Phase II SBIR to Commercialize Direct-to-Digital Pathology Imaging Technology and Initiates New York State-Funded Clinical Pilot Project ACCESS Newswire
24-Jul-2025 Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application ACCESS Newswire
24-Jul-2025 UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2025 ACCESS Newswire
24-Jul-2025 Bausch Health Announces the Appointment of Two New Members to Its Board of Directors ACCESS Newswire
24-Jul-2025 Telomir Pharmaceuticals Reports Telomir-1's Unique Profile Restores Mitochondrial Health While Improving Oxidative Stress Without Promoting Cell Proliferation in Diseased Human Cell Lines Highlighting Potential Relevance to Neurodegenerative Pathways in Alzheimer's and Parkinson's ACCESS Newswire
24-Jul-2025 Tebra Partners With WoundZoom to Simplify Wound Care Management for Independent Practices ACCESS Newswire
24-Jul-2025 DEA Marijuana Rescheduling Judge Mulrooney Retires Amid Constitutional Crisis and MMJ Marijuana Research Lawsuit ACCESS Newswire
24-Jul-2025 AlzeCure's Rights Issue Oversubscribed, And the Company Resolves on A Directed Share Issue Under the Framework of An Overallotment Option ACCESS Newswire
24-Jul-2025 AlzeCure's Rights Issue Oversubscribed According to Preliminary Results ACCESS Newswire
24-Jul-2025 Biovica Awarded 3 MSEK Contract - 4th from Leading Tier-1 Pharma Company ACCESS Newswire
24-Jul-2025 Genflow Biosciences PLC Announces Clinical Readiness Acceleration ACCESS Newswire
23-Jul-2025 Tharimmune Announces Pricing of $1.74 Million Registered Direct Public Offering of Common Stock and Warrants ACCESS Newswire
23-Jul-2025 AlzeCure's Rights Issue Oversubscribed According to Preliminary Results ACCESS Newswire
23-Jul-2025 ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025 ACCESS Newswire
23-Jul-2025 Champions Oncology Reports Record Annual Revenue of $57 Million ACCESS Newswire
23-Jul-2025 Psilocybin Alliance Announces Incorporation and Industry Milestones in Effort to Protect Oregon's Legal Psilocybin Program ACCESS Newswire
23-Jul-2025 Black Book Survey Highlights Growing Divide Over AI Regulation in U.S. Healthcare ACCESS Newswire